Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.95
Jaguar Health, Inc. incurred senior notes of $350,000 aggregate principal amount at 6% per annum maturing one month after issuance.
- Instrument
- senior notes
- Principal
- $350,000 aggregate principal amount
- Rate
- 6% per annum
- Maturity
- one month after issuance
- Event
- incurrence
Exact text from the filing
On January 5, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 (effective 2026-01-05).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- two accredited investors
- Value
- $350,000
- Effective
- 2026-01-05
Exact text from the filing
On January 5, 2026 (the "Execution Date"), Jaguar Health, Inc. (the "Company") entered into securities purchase agreements (the "Securities Purchase Agreements") with two accredited investors (each, an "Investor"), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes
View on SEC.gov